Response to anti-PD-1 based therapy in metastatic melanoma patients is associated with the diversity and composition of the gut microbiome

被引：1
|
作者：
Gopalakrishnan, Vancheswaran
Spencer, Christine
Reuben, Alexandre
Prieto, Peter
Vicente, Diego
Karpinets, Tatiana V.
Hudgens, Courtney W.
Hutchinson, Diane S.
Tetzlaff, Michael
Lazar, Alexander
Davies, Michael A.
Gershenwald, Jeffrey E.
Jenq, Robert
Hwu, Patrick
Sharma, Padmanee
Allison, James
Futreal, Andrew
Ajami, Nadim
Petrosino, Joseph
Daniel-MacDougall, Carrie
Wargo, Jennifer A.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-2672
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2672
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Association of the diversity and composition of the gut microbiome with responses and survival (PFS) in metastatic melanoma (MM) patients (pts) on anti-PD-1 therapy.
    Wargo, Jennifer Ann
    Gopalakrishnan, Vancheswaran
    Spencer, Christine
    Karpinets, Tatiana
    Reuben, Alexandre
    Andrews, Miles Cameron
    Tetzlaff, Michael T.
    Lazar, Alexander
    Hwu, Patrick
    Hwu, Wen-Jen
    Glitza, Isabella Claudia
    Tawbi, Hussein Abdul-Hassan
    Patel, Sapna Pradyuman
    Lee, Jeffrey Edwin
    Davies, Michael A.
    Gershenwald, Jeffrey E.
    Futreal, Andrew
    Sharma, Padmanee
    Allison, James Patrick
    Jenq, Robert R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
    Gopalakrishnan, V.
    Spencer, C. N.
    Nezi, L.
    Reuben, A.
    Andrews, M. C.
    Karpinets, T. V.
    Prieto, P. A.
    Vicente, D.
    Hoffman, K.
    Wei, S. C.
    Cogdill, A. P.
    Zhao, L.
    Hudgens, C. W.
    Hutchinson, D. S.
    Manzo, T.
    de Macedo, M. Petaccia
    Cotechini, T.
    Kumar, T.
    Chen, W. S.
    Reddy, S. M.
    Sloane, R. Szczepaniak
    Galloway-Pena, J.
    Jiang, H.
    Chen, P. L.
    Shpall, E. J.
    Rezvani, K.
    Alousi, A. M.
    Chemaly, R. F.
    Shelburne, S.
    Vence, L. M.
    Okhuysen, P. C.
    Jensen, V. B.
    Swennes, A. G.
    McAllister, F.
    Sanchez, E. Marcelo Riquelme
    Zhang, Y.
    Le Chatelier, E.
    Zitvogel, L.
    Pons, N.
    Austin-Breneman, J. L.
    Haydu, L. E.
    Burton, E. M.
    Gardner, J. M.
    Sirmans, E.
    Hu, J.
    Lazar, A. J.
    Tsujikawa, T.
    Diab, A.
    Tawbi, H.
    Glitza, I. C.
    SCIENCE, 2018, 359 (6371) : 97 - 103
  • [3] The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
    Matson, Vyara
    Fessler, Jessica
    Bao, Riyue
    Chongsuwat, Tara
    Zha, Yuanyuan
    Alegre, Maria-Luisa
    Luke, Jason J.
    Gajewski, Thomas F.
    SCIENCE, 2018, 359 (6371) : 104 - +
  • [4] Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti-PD-1 Therapy
    Szostak, Natalia
    Handschuh, Luiza
    Samelak-Czajka, Anna
    Tomela, Katarzyna
    Pietrzak, Bernadeta
    Schmidt, Marcin
    Galus, Lukasz
    Mackiewicz, Jacek
    Mackiewicz, Andrzej
    Kozlowski, Piotr
    Philips, Anna
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (04) : 427 - 439
  • [5] Association of diversity and composition of the gut microbiome with differential responses to PD-1 based therapy in patients with metastatic melanoma.
    Gopalakrishnan, Vancheswaran
    Spencer, Christine
    Reuben, Alexandre
    Karpinets, Tatiana
    Hutchinson, Diane
    Hoffman, Kristi
    Prieto, Peter A.
    Tetzlaff, Michael T.
    Lazar, Alexander
    Davies, Michael A.
    Gershenwald, Jeffrey E.
    Jenq, Robert R.
    Hwu, Patrick
    Sharma, Padmanee
    Allison, James Patrick
    Futreal, Andrew
    Ajami, Nadim
    Petrosino, Joseph
    Daniel-MacDougall, Carrie
    Wargo, Jennifer A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [6] A Clinical Outcome of the Anti-PD-1 Therapy of Melanoma in Polish Patients Is Mediated by Population-Specific Gut Microbiome Composition
    Pietrzak, Bernadeta
    Tomela, Katarzyna
    Olejnik-Schmidt, Agnieszka
    Galus, Lukasz
    Mackiewicz, Jacek
    Kaczmarek, Mariusz
    Mackiewicz, Andrzej
    Schmidt, Marcin
    CANCERS, 2022, 14 (21)
  • [7] Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers
    Mao, Jinzhu
    Wang, Dongxu
    Long, Junyu
    Yang, Xu
    Lin, Jianzhen
    Song, Yiwei
    Xie, Fucun
    Xun, Ziyu
    Wang, Yanyu
    Wang, Yunchao
    Li, Yiran
    Sun, Huishan
    Xue, Jingnan
    Song, Yang
    Zuo, Bangyou
    Zhang, Junwei
    Bian, Jin
    Zhang, Ting
    Yang, Xiaobo
    Zhang, Lei
    Sang, Xinting
    Zhao, Haitao
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (12)
  • [8] Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
    Hugo, Willy
    Zaretsky, Jesse M.
    Sun, Lu
    Song, Chunying
    Moreno, Blanca Homet
    Hu-Lieskovan, Siwen
    Berent-Maoz, Beata
    Pang, Jia
    Chmielowski, Bartosz
    Cherry, Grace
    Seja, Elizabeth
    Lomeli, Shirley
    Kong, Xiangju
    Kelley, Mark C.
    Sosman, Jeffrey A.
    Johnson, Douglas B.
    Ribas, Antoni
    Lo, Roger S.
    CELL, 2016, 165 (01) : 35 - 44
  • [9] Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy
    Turiello, Roberta
    Capone, Mariaelena
    Giannarelli, Diana
    Morretta, Elva
    Monti, Maria Chiara
    Madonna, Gabriele
    Mallardo, Domenico
    Festino, Lucia
    Azzaro, Rosa
    Levesque, Mitchell P.
    Imhof, Laurence
    Weide, Benjamin
    Amaral, Teresa
    Chevrier, Marc
    Sucker, Antje
    Rutkowski, Piotr
    Schadendorf, Dirk
    Lebbe, Celeste
    Luke, Jason John
    Wistuba-Hamprecht, Kilian
    Dummer, Reinhard
    Pinto, Aldo
    Morello, Silvana
    Ascierto, Paolo A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [10] Limited-duration anti-PD-1 therapy for patients with metastatic melanoma
    Makela, Siru
    Kohtamaki, Laura
    Laukka, Marjut
    Juteau, Susanna
    Hernberg, Micaela
    ACTA ONCOLOGICA, 2020, 59 (04) : 438 - 443
12345